Where do Arbutus Biopharma Corporation's ratios come from?

Every ratio is computed from Arbutus Biopharma Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	81.7%+353pp	-271%+49.5pp	-320.4%+66.1pp	-386.5%+904pp	-1,290.9%-54.1pp
Net margin	84%+322pp	-237.9%+51.6pp	-289.4%+62.5pp	-351.9%+844pp	-1,195.9%-62.8pp
Returns
Return on equity	94.7%+133pp	-38.5%+7.4pp	-45.9%+6.9pp	-52.8%+26.2pp	-79%-10.3pp
Return on invested capital	111.6%+174pp	-62.7%+8.0pp	-70.7%+39.7pp	-110.4%+31.5pp	-141.9%-35.8pp
Efficiency
Asset turnover	1×+0.8×	0.1×0.0×	0.1×0.0×	0.1×+0.1×	0×0.0×
Liquidity
Current ratio	54.3×+38.5×	15.7×-3.1×	18.8×-1.7×	20.5×+14.5×	6×-2.1×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$1.33+233%	$0.40-1.0%	$0.40-6.4%	$0.43+3.9%	$0.42-20.9%
Valuation
Market capitalization	$881.02M+32.6%	$925.08M+6.3%	$870.31M+34.8%	$645.45M-3.4%	$668.27M+7.8%
Price / sales	4.6×-99.1×	65.7×+6.1×	59.6×+17.7×	41.9×-62.5×	104.4×+4.0×
Price / book	3.3×-5.0×	12.1×+0.8×	11.2×+3.5×	7.8×-0.7×	8.4×+2.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Arbutus Biopharma Corporation.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Arbutus Biopharma Corporation's ratios come from?: Every ratio is computed from Arbutus Biopharma Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.